Company Overview

China Feihe Limited is a China-based dairy nutrition company primarily engaged in the production and sale of infant formula and related dairy products. The company operates within the consumer staples and dairy nutrition industry, with a strategic focus on premium and super-premium infant formula tailored to Chinese consumers. Its core revenue is generated from infant milk formula products marketed under the Feihe brand portfolio, which emphasizes product safety, traceability, and formulations designed for different developmental stages.

The company is widely recognized for its “China-based milk source” strategy, controlling the full value chain from dairy farming to manufacturing and distribution. Founded in 1962 as a state-owned dairy enterprise, Feihe transitioned through restructuring and privatization before listing on the Hong Kong Stock Exchange in 2019. Over time, it evolved from a regional dairy producer into one of China’s leading domestic infant formula brands, benefiting from consumer preference shifts toward trusted local brands following food safety reforms in China.

Business Operations

China Feihe operates primarily through its infant formula business segment, which accounts for the majority of its revenue, alongside smaller contributions from adult nutrition products, liquid milk, and nutritional supplements. The company generates revenue through direct sales to distributors, maternal-and-child retail stores, and e-commerce platforms. Its vertically integrated model includes self-owned dairy farms, milk processing facilities, and proprietary research and development capabilities.

Operationally, Feihe controls upstream assets such as large-scale dairy farms and milk collection systems, as well as downstream manufacturing plants certified under Chinese and international food safety standards. The company maintains multiple wholly owned subsidiaries responsible for farming, production, sales, and logistics. While Feihe does not rely heavily on joint ventures, it has engaged in research collaborations with academic institutions to support product development and nutritional science.

Strategic Position & Investments

Strategically, China Feihe positions itself as a premium domestic alternative to foreign infant formula brands, leveraging localized research, Chinese maternal data, and full supply-chain control. Growth initiatives have focused on product premiumization, expansion of super-premium formula lines, and increased penetration in lower-tier Chinese cities. The company has also invested significantly in brand marketing, consumer education, and scientific research to strengthen long-term brand equity.

Feihe has made notable investments in upstream dairy farming infrastructure and nutrition research centers to enhance milk quality and formulation capabilities. It has also expanded into adjacent nutrition categories, including children’s and adult dairy nutrition products. While acquisitions have not been the primary growth driver, the company has selectively invested in assets and technologies that reinforce supply-chain security and product differentiation. Public disclosures indicate ongoing exploration of functional nutrition and precision-formula development, though commercial impact remains limited.

Geographic Footprint

China Feihe’s operations are primarily concentrated in Mainland China, which accounts for the vast majority of its revenue and assets. Its headquarters are located in Beijing, while major dairy farms and production facilities are situated in Heilongjiang Province, a region known for favorable dairy farming conditions. The company’s distribution network spans all major Chinese provinces, with particularly strong penetration in northern and lower-tier cities.

Internationally, Feihe has a limited but growing footprint, including dairy farming assets and supply-chain investments in North America, intended to diversify milk sources and support long-term raw material security. While overseas sales remain immaterial relative to domestic revenue, the company maintains export registrations and regulatory approvals for select international markets, reflecting a cautious and incremental approach to global expansion.

Leadership & Governance

China Feihe was founded by Leng Youbin, who continues to play a central role in shaping the company’s long-term strategy and corporate culture. Leadership emphasizes product quality, scientific rigor, and supply-chain control as core governance principles. The company is overseen by a board of directors and management team with experience in dairy operations, consumer branding, and finance, consistent with requirements of a Hong Kong–listed issuer.

Key executives include:

• Leng Youbin – Chairman and Chief Executive Officer
• Liu Hua – Executive Director
• Zhang Shuhui – Chief Financial Officer
• Zhao Zhijun – Vice President, Sales and Marketing
• Wang Zhigang – Vice President, Research and Development

The leadership team’s strategic vision centers on maintaining Feihe’s leadership in China’s infant formula market through continuous investment in quality, compliance, and consumer trust.